784966008: Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Product containing guanethidine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing adrenal hormone (product)\Adrenal medulla hormone-containing product\Adrenaline-containing product\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing adrenal hormone (product)\Adrenal medulla hormone-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing adrenal hormone (product)\Adrenal medulla hormone-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Adrenaline-containing product\...

\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Product manufactured as ocular dose form (product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product manufactured as ocular dose form (product)\Product containing guanethidine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Autonomic drug (substance)\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Product containing guanethidine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765863011 Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3765864017 Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3765865016 Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3765863011 Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3765864017 Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3765865016 Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator unit (attribute)	Milliliter (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Plays role	Antiglaucoma therapeutic role	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has manufactured dose form	Eye solution	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Count of base of active ingredient	deux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator unit (attribute)	Milliliter (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Is a	Adrenaline and guanethidine only product in ocular dose form	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator value	2.5	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has precise active ingredient	Epinephrine bitartrate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has basis of strength substance (attribute)	Adrenaline	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator value	500	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has precise active ingredient	Guanethidine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator unit	mcg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has basis of strength substance (attribute)	Guanethidine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765863011	Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3765864017	Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3765865016	Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3765863011	Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3765864017	Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3765865016	Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core